CoChat
Sign Up
Cited by 9

The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.

The low density lipoprotein receptor: Structure, function and pharmacological modulation

Catapano, Alberico L.·1989·Pharmacology & Therapeutics
DOI 10.1016/0163-7258(89)90118-6
Open this paper in CoChat — free account

Overview

Integrity signals

Registry

Crossref · 10.1016/0163-7258(89)90118-6

Cites

2 of 2 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Flagged first, then by citations

Research works printed but not linked: 112

  1. Anderson, 1982, Surface distribution and recycling of the low density lipoprotein receptor as visualized with antireceptor antibodies, J. Cell Biol., 93, 523, 10.1083/jcb.93.3.523 · DOI
  2. Anderson, 1977, Role for the coated endocytic vesicle in the uptake of receptor-bound low density lipoprotein in human fibroblasts, Cell, 10, 351, 10.1016/0092-8674(77)90022-8 · DOI · Paper page
  3. Anderson, 1977, A mutation that impairs the ability of lipoprotein receptors to localize in pits on the cell surface of human fibroblasts, Nature, 270, 695, 10.1038/270695a0 · DOI
  4. Anderson, 1978, Immunocytochemical visualization of coated pits and vesicles in human fibroblasts: relation to low density lipoprotein receptor distribution, Cell, 15, 919, 10.1016/0092-8674(78)90276-3 · DOI
  5. Beynen, 1986, Mechanism of casein-induced hypercholesterolemia: primary and secondary features, Atherosclerosis, 60, 291, 10.1016/0021-9150(86)90177-2 · DOI
  6. Bhattacharya, 1986, Regulation of low-density-lipoprotein metabolism in the rat, Biochem. J., 234, 493, 10.1042/bj2340493 · DOI
  7. Bilheimer, 1984, Liver transplantation to provide low density lipoprotein receptors and lower plasma cholesterol in a child with homozygous familial hypercholesterolemia, New Engl. J. Med., 311, 1658, 10.1056/NEJM198412273112603 · DOI
  8. Brown, 1981, Lowering plasma cholesterol by raising LDL receptors, New Engl. J. Med., 305, 515, 10.1056/NEJM198108273050909 · DOI
  9. Brown, 1983, Recycling receptors: the round-trip itinerary of migrant membrane proteins, Cell, 32, 666, 10.1016/0092-8674(83)90052-1 · DOI · Paper page
  10. Brown, 1986, A receptor-mediated pathway for cholesterol homeostasis, Science, 232, 34, 10.1126/science.3513311 · DOI · Paper page
  11. Brown, 1981, Regulation of plasma cholesterol by lipoprotein receptors, Science, 212, 628, 10.1126/science.6261329 · DOI · Paper page
  12. Buchwald, 1985, Surgical intervention in atherosclerosis: partial ileal bypass and the program on surgical control of the hyperlipidemias (POSCH), Pharmac. Ther., 29, 93, 10.1016/0163-7258(85)90018-X · DOI
  13. Cayen, 1979, Pharmacokinetics and hypolipidemic activity of clofibrate-nicotinic acid combinations in rats, Biochem. Pharmac., 28, 1163, 10.1016/0006-2952(79)90323-X · DOI
  14. Carpentier, 1986, Internalization of polypeptide hormones and receptor recycling, Experientia, 42, 734, 10.1007/BF01941519 · DOI
  15. Catapano, 1987, Binding sites for HDL and HDL catabolism, Atherosclerosis Rev., 16, 109
  16. Catapano, 1989, Competitive inhibitors of HMG-CoA reductase, Pharmac. Res. Commun.
  17. Chait, 1979, Regulatory role of triiodothyronine in the degradation of low density lipoprotein by cultured human skin fibroblast, J. clin. Endocr. Metab., 48, 887, 10.1210/jcem-48-5-887 · DOI
  18. Chait, 1979, Low density lipoprotein receptor activity in cultured human skin fibroblasts; mechanisms of insulin-induced stimulation, J. clin. Invest., 64, 1309, 10.1172/JCI109587 · DOI
  19. Chait, 1981, Acceleration of low-density lipoprotein catabolism in man by total parenteral nutrition (41240), P.E.E.B.M., 168, 97
  20. Chao, 1982, Effects of cholestyramine on low density lipoprotein binding sites on liver membranes from rabbits with endogenous hypercholesterolemia induced by a wheat starch-casein diet, J. biol. Chem., 257, 3623, 10.1016/S0021-9258(18)34825-7 · DOI
  21. Chute, 1985, Reducing of plasma cholesterol and LDL-cholesterol by continuous intravenous insulin infusion, Surgery, 98, 656
  22. Corsini, 1986, Calcium antagonists and low density lipoprotein metabolism by human fibroblasts and by human hepatoma cell line Hep G2, Pharmac. Res. Commun., 18, 1, 10.1016/0031-6989(86)90155-4 · DOI
  23. Cummings, 1983, Biosynthesis of N- and O-linked oligosaccharides of the low density lipoprotein receptor, J. biol. Chem., 258, 15261, 10.1016/S0021-9258(17)43802-6 · DOI
  24. Davis, 1986, Deletion of clustered O-linked carbohydrates does not impair function of low density lipoprotein receptor in transfected fibroblasts, J. biol. Chem., 261, 2828, 10.1016/S0021-9258(17)35862-3 · DOI
  25. Davis, 1986, The D.J. Mutation in familial hypercholesterolemia: amino acid substitution in cytoplasmic domain impedes internalization of LDL Receptor, Cell, 45, 15, 10.1016/0092-8674(86)90533-7 · DOI · Paper page
  26. Davis, 1987, The low density lipoprotein receptor, J. biol. Chem., 262, 4075, 10.1016/S0021-9258(18)61313-4 · DOI · Paper page
  27. Eisenberg, 1984, Abnormalities in very low, low and high density lipoproteins in hypertriglyceridemia, J. clin. Invest., 74, 470, 10.1172/JCI111444 · DOI
  28. Endo, 1985, Drugs inhibiting HMG-CoA reductase, Pharmac. Ther., 31, 257, 10.1016/0163-7258(85)90025-7 · DOI
  29. Epstein, 1983, Cholesterol coronary heart disease cancer and diet: some current controversies, Atherosclerosis Rev., 11, 1
  30. Fears, 1984, Drug treatment of hyperlipidaemia, Drugs of Today, 20, 257
  31. Filipovic, 1986, Calcium channels stimulate LDL receptor synthesis in human skin fibroblasts, Biochem. biophys. Res. Commun., 136, 845, 10.1016/0006-291X(86)90409-2 · DOI
  32. Frick, 1987, Helsinki heart study: primary-prevention trial with gemfibrozil in middle-aged men with dyslipidemia, New Engl. J. Med., 317, 1237, 10.1056/NEJM198711123172001 · DOI · Paper page
  33. Gofman, 1951, Lipoproteins and atherosclerosis, J. Gerontol., 6, 105, 10.1093/geronj/6.2.105 · DOI
  34. Goldstein, 1974, Binding and degradation of low density lipoproteins by cultured human fibroblasts: comparison of cells from a normal subject and from a patient with homozygous familial hypercholesterolemia, J. biol. Chem., 249, 5153, 10.1016/S0021-9258(19)42341-7 · DOI · Paper page
  35. Goldstein, 1977, The low-density lipoprotein pathway and its relation to atherosclerosis, A. Rev. Biochem., 46, 897, 10.1146/annurev.bi.46.070177.004341 · DOI · Paper page
  36. Goldstein, 1984, Progress in understanding the LDL receptor and HMG-CoA reductase, two membrane proteins that regulate the plasma cholesterol, J. Lipid Res., 25, 1450, 10.1016/S0022-2275(20)34418-7 · DOI
  37. Goldstein, 1987, Regulation of low-density lipoproteins receptors: implications for pathogenesis and therapy of hypercholesterolemia and atherosclerosis, Circulation, 76, 504, 10.1161/01.CIR.76.3.504 · DOI · Paper page
  38. Goldstein, 1978, Role of lysosomal acid lipase in the metabolism of plasma low density lipoproteins, J. biol. Chem., 250, 8487, 10.1016/S0021-9258(19)40786-2 · DOI
  39. Goldstein, 1979, Inhibition of cholesterol synthesis with compactin renders growth of cultured cells dependent on the low density lipoprotein receptor, J. biol. Chem., 254, 5403, 10.1016/S0021-9258(18)50610-4 · DOI
  40. Gordon, 1977, High density lipoprotein as a protective factor against coronary heart disease. The Framingham study, Am. J. Med., 62, 707, 10.1016/0002-9343(77)90874-9 · DOI · Paper page
  41. Grundy, 1986, Liver lipoproteins and atherosclerosis: an overview, Atherosclerosis Rev., 15, 1
  42. Grundy, 1987, Dietary therapy for different forms of hyperlipoproteinemia, Circulation, 76, 523, 10.1161/01.CIR.76.3.523 · DOI
  43. Hegsted, 1965, Quantitative effects of dietary fat on serum cholesterol in man, Am. J. clin. Nutr., 17, 281, 10.1093/ajcn/17.5.281 · DOI
  44. Hobbs, 1986, Deletion of exon encoding cysteine-rich repeat of low density lipoprotein receptor alters its binding specificity in a subject with familial hypercholesterolemia, J. biol. Chem., 261, 13114, 10.1016/S0021-9258(18)69278-6 · DOI
  45. Hobbs, 1987, Deletion in the gene for the low-density-lipoprotein receptor in a majority of French Canadians with familial hypercholesterolemia, New Engl. J. Med., 317, 734, 10.1056/NEJM198709173171204 · DOI
  46. Hoeg, 1987, 3-hydroxy-3-methylglutaryl-coenzyme A reductase inhibitors in the treatment of hypercholesterolemia, JAMA, 258, 3532, 10.1001/jama.258.24.3532 · DOI
  47. Hoeg, 1986, An approach to the management of hyperlipoproteinemia, JAMA, 255, 512, 10.1001/jama.255.4.512 · DOI
  48. Horsthemke, 1987, Unequal crossing-over between two alu-repetitive DNA sequences in the low density lipoprotein receptor gene. A possible mechanism for the defect in a patient with familial hypercholesterolemia, Eur. J. Biochem., 164, 77, 10.1111/j.1432-1033.1987.tb10995.x · DOI
  49. Hui, 1986, Isolation and characterization of the apolipoprotein E receptor from canine and human liver, J. biol. Chem., 261, 4256, 10.1016/S0021-9258(17)35655-7 · DOI
  50. Kempen, 1987, Effect of ketoconazole on cholesterol synthesis and on HMG-CoA reductase and LDL-receptor activities in hep G2 cells, Biochem. Pharmac., 36, 1245, 10.1016/0006-2952(87)90077-3 · DOI
  51. Kesäniemi, 1983, Receptor-mediated catabolism of low density lipoprotein, J. clin. Invest., 71, 950, 10.1172/JCI110849 · DOI
  52. Keys, 1970, Coronary heart disease in seven countries, Circulation, 41, I
  53. Keys, 1965, Serum cholesterol responses to changes in diet. IV. Particular saturated fatty acids in the diet, Metabolism, 14, 776, 10.1016/0026-0495(65)90004-1 · DOI
  54. Kishimoto, 1987, Phosphorylation of serine 833 in cytoplasmic domain of low density lipoprotein receptor by a high molecular weight enzyme resembling casein kinase II, J. biol. Chem., 262, 1344, 10.1016/S0021-9258(19)75792-5 · DOI
  55. Knott, 1986, Complete protein sequence and identification of structural domains of human apolipoprotein B, Nature, 323, 734, 10.1038/323734a0 · DOI
  56. Koo, 1986, Uptake of canine β very low density lipoprotein by mouse peritoneal macrophages is mediated by a low density lipoprotein receptor, J. biol. Chem., 261, 11194, 10.1016/S0021-9258(18)67367-3 · DOI
  57. Kovanen, 1979, Increased binding of low density lipoprotein of liver membranes from rats treated with 17 alpha-ethinyl estradiol, J. biol. Chem., 254, 11367, 10.1016/S0021-9258(19)86495-5 · DOI
  58. Lehrman, 1985, Internalization-defective LDL receptors produced by gene with nonsense and frameshift mutations that truncate the cytoplasmic domain, Cell, 41, 735, 10.1016/S0092-8674(85)80054-4 · DOI
  59. Lehrman, 1987, Duplication of seven exons in LDL receptor gene causes by alu-alu recombination in a subject with familial hypercholesterolemia, Cell, 48, 827, 10.1016/0092-8674(87)90079-1 · DOI
  60. Lehrman, 1987, Alu-alu recombination deletes splice acceptor sites and produces secreted low density lipoprotein receptors in a subject with familial hypercholesterolemia, J. biol. Chem., 262, 3354, 10.1016/S0021-9258(18)61510-8 · DOI
  61. Lehrman, 1987, The lebanese allele at the low density lipoprotein receptor locus, J. biol. Chem., 262, 401, 10.1016/S0021-9258(19)75941-9 · DOI
  62. Lehrman, 1985, Mutation in LDL receptor: alu-alu recombination deletes exons encoding transmembrane and cytoplasmic domains, Science, 227, 140, 10.1126/science.3155573 · DOI
  63. Lipid Research Clinics Program, 1984, The lipid research clinics coronary primary prevention trial results: I. Reduction in incidence of coronary heart disease, JAMA, 251, 351, 10.1001/jama.251.3.351 · DOI · Paper page
  64. Lovati, 1987, Soybean protein diet increases low density lipoprotein receptor activity in mononuclear cells from hypercholesterolemic patients, J. clin. Invest., 80, 1498, 10.1172/JCI113232 · DOI
  65. Mahley, 1983, Lipoprotein receptors and cholesterol homeostasis, Biochim. biophys. Acta, 737, 197, 10.1016/0304-4157(83)90001-1 · DOI
  66. Miettinen, 1975, Bile acid metabolism, Vol. 41, 109
  67. Nishikura, 1986, Studies and perspectives of protein kinase C, Science, 233, 305, 10.1126/science.3014651 · DOI
  68. Oram, 1983, Regulation of high density lipoprotein receptor activity in cultured human skin fibroblasts and human arterial smooth muscle cells, J. clin. Invest., 72, 1611, 10.1172/JCI111120 · DOI
  69. Prasad, 1985, Coat formation in coated vesicles, Biochemistry, 24, 6421, 10.1021/bi00344a017 · DOI
  70. Ranganathan, 1982, Effect of Ca2+ blocking agents on the metabolism of low density lipoprotein in human skin fibroblasts, Biochem. biophys. Res. Commun., 107, 217, 10.1016/0006-291X(82)91691-6 · DOI
  71. Roach, 1987, The effects of dietary fish oil on hepatic high density and low density lipoprotein receptor activities in the rat, FEBS Lett., 222, 159, 10.1016/0014-5793(87)80211-9 · DOI
  72. Russell, 1984, Domain map of the LDL receptor: sequence homology with the epidermal growth factor precursor, Cell, 37, 577, 10.1016/0092-8674(84)90388-X · DOI · Paper page
  73. Salter, 1987, Binding of low density lipoprotein to monolayer cultures of rat hepatocytes is increased by insulin and decreased by dexamethasone, FEBS Lett., 220, 159, 10.1016/0014-5793(87)80895-5 · DOI
  74. Scarabottolo, 1986, Experimental hypothyroidism modulates the expression of the low density lipoprotein receptor by the liver, Atherosclerosis, 59, 329, 10.1016/0021-9150(86)90129-2 · DOI
  75. Schneider, 1983, Reconstitution of low density lipoprotein receptor, J. Cell. Biochem., 23, 95, 10.1002/jcb.240230110 · DOI
  76. Schneider, 1982, Purification of the low density lipoprotein receptor, an acidic glycoprotein of 164,000 molecular weight, J. biol. Chem., 257, 2664, 10.1016/S0021-9258(18)34975-5 · DOI · Paper page
  77. Sege, 1984, Expression and regulation of human low density lipoprotein receptors in Chinese hamster ovary cells, Nature, 307, 742, 10.1038/307742a0 · DOI
  78. Semenkovich, 1987, Estrogen induced low-density lipoprotein receptor activity and decrease intracellular cholesterol in human hepatoma cell line hep G2, Biochem., 26, 4987, 10.1021/bi00390a016 · DOI
  79. Series, 1988, Influence of etofibrate on low density lipoprotein metabolism, Atherosclerosis, 69, 233, 10.1016/0021-9150(88)90019-6 · DOI
  80. Shannon-Moore, 1987, Assembly of clathrin-coated pits onto purified plasma membranes, Science, 236, 558, 10.1126/science.2883727 · DOI
  81. Shepherd, 1979, Receptor-mediated low density lipoprotein catabolism in man, J. Lipid Res., 20, 999, 10.1016/S0022-2275(20)40002-1 · DOI
  82. Shepherd, 1980, Cholestyramine promotes receptor-mediated low-density-lipoprotein catabolism, New Engl. J. Med., 302, 1219, 10.1056/NEJM198005293022202 · DOI
  83. Sirtori, 1977, Soy bean-protein diet in the treatment of type II hyperlipoproteinemia, Lancet, II, 275, 10.1016/S0140-6736(77)91823-2 · DOI
  84. Sirtori, 1984, Effects of dietary proteins on the regulation of liver lipoprotein receptors in rats, J. Nutr., 114, 1493, 10.1093/jn/114.8.1493 · DOI
  85. Slater, 1980, Effects of cholestyramine on receptor-mediated plasma clearance and tissue uptake of human low density lipoproteins in the rabbit, J. biol. Chem., 255, 10210, 10.1016/S0021-9258(19)70450-5 · DOI
  86. Spady, 1985, Rates of low density lipoprotein uptake and cholesterol synthesis are regulated indepently in the liver, J. Lipid Res., 26, 465, 10.1016/S0022-2275(20)34361-3 · DOI
  87. Spady, 1986, Kinetic constants for receptor-dependent and receptor-independent low density lipoprotein transport in the tissues of the rat and hamster, J. clin. Invest., 77, 1474, 10.1172/JCI112460 · DOI
  88. Spengel, 1981, Superiority of partial ileal bypass over cholestyramine in reducing cholesterol in familial hypercholesterolemia, Lancet, I, 768, 10.1016/S0140-6736(81)90183-5 · DOI
  89. Stahl, 1986, Receptor-mediated endocytosis, J. clin. Invest., 77, 657, 10.1172/JCI112359 · DOI
  90. Stalenhoef, 1984, Partial ileal bypass reduces the production rate of low density lipoproteins in Watanabe heritable hyperlipemid rabbits, J. Lipid Res., 25, 1350, 10.1016/S0022-2275(20)34452-7 · DOI
  91. Stange, 1984, Age-related decreases in tissue sterol aquisition are mediated by changes in cholesterol synthesis and not low density lipoprotein uptake in the rat, J. Lipid Res., 25, 703, 10.1016/S0022-2275(20)37759-2 · DOI
  92. Stein, 1985, Verapamil enhances receptor-mediated endocytosis of low density lipoproteins by aortic cells in culture, Atherosclerosis, 5, 35
  93. Stewart, 1982, Effects of bezafibrate on receptor-mediated and receptor-independent low density lipoprotein catabolism in type II hyperlipoproteinaemic subject, Atherosclerosis, 44, 355, 10.1016/0021-9150(82)90010-7 · DOI
  94. Storlien, 1987, Fish oil prevents insulin resistance induced by high-fat feeding in rats, Science, 237, 885, 10.1126/science.3303333 · DOI
  95. Südhof, 1985, The LDL receptor gene: a mosaic of exons shared with dofferent proteins, Science, 228, 815, 10.1126/science.2988123 · DOI · Paper page
  96. Südhof, 1985, Cassette of eight exons shared by genes for LDL receptors and EGF precursor, Science, 228, 893, 10.1126/science.3873704 · DOI
  97. Südhof, 1987, 4ä bp element of LDL receptor gene confers end-product repression by sterols when inserted into viral TK promoter, Cell, 48, 1061, 10.1016/0092-8674(87)90713-6 · DOI · Paper page
  98. Südhof, 1987, Three direct repeats and a TATA-like sequence are required for regulated expression of the human low density lipoprotein receptor gene, J. biol. Chem., 262, 10773, 10.1016/S0021-9258(18)61030-0 · DOI · Paper page
  99. Sykes, 1981, The effects of hypothyroidism, age and nutrition on LDL catabolism in the rat, Metabolism, 30, 733, 10.1016/0026-0495(81)90017-2 · DOI
  100. Tobert, 1987, New developments in lipid lowering therapy: the role of inhibitors of hydroxymethylglutaryl coenzyme A reductase, Circulation, 76, 534, 10.1161/01.CIR.76.3.534 · DOI
  101. Tolleshaug, 1982, Posttranslational processing of the LDL receptor and its genetic disruption in familial hypercholesterolemia, Cell, 30, 715, 10.1016/0092-8674(82)90276-8 · DOI · Paper page
  102. Tolleshaug, 1983, The LDL receptor locus in familial hypercholesterolemia: multiple mutations disrupt transport and processing of a membrane receptor, Cell, 32, 914, 10.1016/0092-8674(83)90079-X · DOI
  103. Trezzi, 1984, Effects of insulin defiency on the catabolism of plasma lipoproteins and on the expression of hepatic lipoprotein receptors in rat, Pharm. Res. Commun., 16, 539, 10.1016/S0031-6989(84)80035-1 · DOI
  104. Trezzi, 1983, Effect of partial ileal bypass on plasma clearance and binding of lipoproteins to liver membranes in the rabbit, Atherosclerosis, 46, 269, 10.1016/0021-9150(83)90177-6 · DOI
  105. Undewood, 1986, A thyromimetic that decreases plasma cholesterol levels without increasing cardiac activity, Nature, 324, 425, 10.1038/324425a0 · DOI
  106. Van Niekerk, 1983, Partial ileal bypass inhibits atherosclerosis in WHHL rabbits, Atherosclerosis, 48, 243, 10.1016/0021-9150(83)90042-4 · DOI
  107. Vega, 1988, Lovastatin therapy in familial dysbetalipoproteinemia: effect on kinetics of apolipoprotein B, Atherosclerosis, 70, 131, 10.1016/0021-9150(88)90107-4 · DOI
  108. Weinstein, 1987, Antiatherogenic properties of calcium antagonists, Am. J. Cardiol., 59, 163B, 10.1016/0002-9149(87)90097-X · DOI
  109. Wileman, 1985, Receptor-mediated endocytosis, Biochem. J., 232, 1, 10.1042/bj2320001 · DOI
  110. Wong, 1987, Eicosapentaenoc acid inhibits the secretion of triacylglycerol and of apoprotein B and the binding of LDL in Hep G2 cells, Atherosclerosis, 64, 139, 10.1016/0021-9150(87)90239-5 · DOI
  111. Yamamoto, 1985, Deletion in cysteine-rich of LDL receptor impedes transport to cell surface in WHHL rabbit, Science, 232, 1230, 10.1126/science.3010466 · DOI
  112. Yamamoto, 1984, The human LDL receptor: a cysteine-rich protein with multiple alu sequences in its mRNA, Cell, 39, 27, 10.1016/0092-8674(84)90188-0 · DOI · Paper page

Cited by

Sorted by citations

Metadata

Authors
Catapano, A. L.
Venue
Pharmacology & Therapeutics
Publisher
Elsevier BV
Published
1989-01
Volume
43
Issue
2
Pages
187-219
ISSN
0163-7258
DOI
10.1016/0163-7258(89)90118-6
Cited by
9
References
2
Language
en
Licence
www.elsevier.com/tdm/userlicense/1.0/ (tdm)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review